Tepat 1.0 COVID-19 Test Kit

Cellbae tepat 10 covid19 test kit alternate 800

1.5 hours from RNA to results

100% coverage with 100% identity of all SARS-CoV-2 genomes in the world

Detects 6 copies of viral RNA (0.24 copies/uL)

Multiplex RdRp and M viral genes detection enhances sensitivity and specificity

Whole process control: human RNase P

1.5 hours from RNA to results

100% coverage with 100% identity of all SARS-CoV-2 genomes in the world

Detects 6 copies of viral RNA (0.24 copies/uL)

Multiplex RdRp and M viral genes detection enhances sensitivity and specificity

Whole process control: human RNase P

Cellbae tepat 10 covid19 test kit alternate 800

The Cellbae Multiplex RT-PCR kit provides for high-throughput, sensitive and specific detection of SARS-CoV-2 RNA extracted from nasopharyngeal swabs*. It can detect 6 copies of viral RNA per reaction with > 95% confidence. Clinical validation shows 100% sensitivity, with no cross-reaction with non-SARS-CoV-2 species.

Workflow

Sampling

RNA Extraction

RT-PCR

Data Analysis

Kit Components

100 Tests/Kit

Component Volume (100 Tests)
Master Mix A
1250 μL
Master Mix B
150 μL
Positive Control
100 μL
Internal Control
100 μL

Multiplexed Detection

Multiplexed dectection chart

Kit Specification

Targets

RdRp, M and RNase P genes

Inclusivity

100% coverage of all SARS-CoV-2 genomes (as of Aug. 10, 2020)

Turnaround Time

1.5 hours

Limit of Detection

6 copies per reaction

Storage / Shelf life

-25 to -15oC / 6 months

Validated Machines

Bio-Rad CFX96, LightCycler 480 II

Sensitivity / Specificity

100% / 100% (CV: < 4%)

Certification

Singapore Health Sciences Authority (HSA) MDPA2020-127 received Sept. 15, 2020

*A positive result from the test may indicate the presence of SARS-CoV-2-specific RNA in the test sample. If the test result is negative and clinical symptoms persist, additional testing using other clinical methods is recommended. A negative result does not at any time preclude the possibility of SARS-COV-2 infection.

Express your interest here.